We publish the information note issued by AIFA regarding the lack of Ritmodan Retard®.
As you can read in the information note, the Marketing Authorization Holder (AIC) of Ritmodan Retard®, the pharmaceutical company Cheplapharm Arzneimittel Gmbh, has officially communicated the status of shortage only in
date 12 July 2021, indicating as the reason for the shortage problems with the supply of the active ingredient. The shortage is scheduled to end today on 1 November 2021.
The information note includes the instructions, procedures and forms necessary to request the import of the drug.
You can download the document and all attachments using the appropriate button in the bar below the box in which it is presented.